Suppr超能文献

仓鼠抵抗致死性系统性水疱性口炎病毒感染的保护介质:缺陷干扰颗粒、聚肌苷酸-聚胞苷酸和干扰素。

Mediators of protection against lethal systemic vesicular stomatitis virus infection in hamsters: defective interfering particles, polyinosinate-polycytidylate, and interferon.

作者信息

Fultz P N, Shadduck J A, Kang C Y, Streilein J W

出版信息

Infect Immun. 1982 Aug;37(2):679-86. doi: 10.1128/iai.37.2.679-686.1982.

Abstract

Homologous defective interfering (DI) particles protected adult Syrian hamsters against lethal systemic infection with vesicular stomatitis virus (VSV) serotype Indiana. The DI particles had to be biologically active, but did not have to be administered at the same inoculation site as the infectious virus. Serum and tissue levels of VSV postinoculation were significantly lower in DI-protected animals than in unprotected controls, suggesting that true autointerference was occurring. However, some aspects of protection also must be mediated through nonspecific mechanisms, since susceptible hamsters could be protected against VSV Indiana by coinjection with heterologous DI particles prepared from VSV serotype New Jersey or by simultaneous administration of polyinosinic acid-polycytidylic acid. By measuring serum levels of putative hamster interferon (type 1), we found that animals coinjected with VSV and DI particles or polyinosinic acid-polycytidylic acid produced significant levels of interferon. Since similarly high serum levels of interferon were measured in recipients of VSV alone (animals that eventually died from infection), there appeared to be no correlation between protection against lethal disease and induced levels of serum interferon. Instead, serum interferon levels correlated positively with amounts of VSV PFU found in serum and tissues of infected animals, the lowest levels being found in serum of animals protected with homologous DI particles. The data are consistent with the hypothesis that autointerference by DI particles as well as various host defense mechanisms (possibly including induction of interferon) participates in protecting hamsters against lethal VSV infection.

摘要

同源缺陷干扰(DI)颗粒可保护成年叙利亚仓鼠免受水泡性口炎病毒(VSV)印第安纳血清型的致死性全身感染。DI颗粒必须具有生物活性,但不必与感染性病毒在同一接种部位给药。接种后,DI颗粒保护组动物的VSV血清和组织水平显著低于未保护的对照组,这表明真正的自身干扰正在发生。然而,保护的某些方面也必须通过非特异性机制介导,因为易感仓鼠可通过与由新泽西血清型VSV制备的异源DI颗粒共同注射或同时给予聚肌苷酸-聚胞苷酸来抵抗VSV印第安纳血清型感染。通过测量假定的仓鼠干扰素(1型)的血清水平,我们发现与VSV和DI颗粒或聚肌苷酸-聚胞苷酸共同注射的动物产生了显著水平的干扰素。由于仅接种VSV的动物(最终死于感染的动物)也测量到了同样高的血清干扰素水平,因此针对致死性疾病的保护与诱导的血清干扰素水平之间似乎没有相关性。相反,血清干扰素水平与感染动物血清和组织中发现的VSV空斑形成单位(PFU)数量呈正相关,在用同源DI颗粒保护的动物血清中发现的水平最低。这些数据与以下假设一致,即DI颗粒的自身干扰以及各种宿主防御机制(可能包括干扰素的诱导)参与保护仓鼠免受致死性VSV感染。

相似文献

5
Requirements for DI particle prophylaxis against vesicular stomatitis virus infection in vivo.
J Gen Virol. 1980 Jul;49(1):215-20. doi: 10.1099/0022-1317-49-1-215.
6
Genetic analysis of resistance to lethal infections of vesicular stomatitis virus in Syrian hamsters.
Infect Immun. 1981 Jun;32(3):1007-13. doi: 10.1128/iai.32.3.1007-1013.1981.
9
Defective interfering virus particles modulate virulence.
J Virol. 1985 Aug;55(2):366-73. doi: 10.1128/JVI.55.2.366-373.1985.

引用本文的文献

2
Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration.
Front Pharmacol. 2022 Aug 17;13:965789. doi: 10.3389/fphar.2022.965789. eCollection 2022.
4
Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?
J Virol. 2014 May;88(10):5217-27. doi: 10.1128/JVI.03193-13. Epub 2014 Feb 26.
7
A defective interference-like phenomenon of human hepatitis B virus in chronic carriers.
J Virol. 1998 Jan;72(1):578-84. doi: 10.1128/JVI.72.1.578-584.1998.
8
Pathogenesis of mucosal disease: a cytopathogenic pestivirus generated by an internal deletion.
J Virol. 1994 May;68(5):3289-97. doi: 10.1128/JVI.68.5.3289-3297.1994.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.
J Biol Chem. 1951 Nov;193(1):265-75.
4
Genetic analysis of resistance to lethal infections of vesicular stomatitis virus in Syrian hamsters.
Infect Immun. 1981 Jun;32(3):1007-13. doi: 10.1128/iai.32.3.1007-1013.1981.
5
Requirements for DI particle prophylaxis against vesicular stomatitis virus infection in vivo.
J Gen Virol. 1980 Jul;49(1):215-20. doi: 10.1099/0022-1317-49-1-215.
8
Interaction between interferon and host genes in antiviral defense.
Ann N Y Acad Sci. 1980;350:558-65. doi: 10.1111/j.1749-6632.1980.tb20657.x.
9
The induction and characterization of interferon from pure cultures of murine macrophages.
Ann N Y Acad Sci. 1980;350:413-21. doi: 10.1111/j.1749-6632.1980.tb20643.x.
10
Defective viral particles and viral disease processes.
Nature. 1970 Apr 25;226(5243):325-7. doi: 10.1038/226325a0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验